Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danny Ka-Ho Wong
Man-Fung Yuen

Showing results (1-10 of 480) with videos related to

Pageof 48
Sort By:
The Lancet. Infectious Diseases|March 28, 2009
Prevention and management of drug resistance for antihepatitis B treatmentMan-Fung Yuen, James Fung, Danny Ka-Ho Wong, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 21, 2014
Hepatitis B surface antigen levels after hepatitis B e-antigen seroclearance: a longitudinal follow-up studyJames Fung, Wai-Kay Seto, Danny Ka-ho Wong, et al.
Journal of Clinical Microbiology|October 9, 2004
HBsAg seroclearance in Chinese patients receiving lamivudine therapy for chronic hepatitis B virus infectionMan-Fung Yuen, Danny Ka-Ho Wong, He-Jun Yuan, et al.
Antiviral Therapy|February 17, 2007
One-year entecavir or lamivudine therapy results in reduction of hepatitis B virus intrahepatic covalently closed circular DNA levelsDanny Ka-Ho Wong, Man-Fung Yuen, Vincent Wing-Shun Ngai, et al.
Oncotarget|October 7, 2015
Estradiol induces apoptosis via activation of miRNA-23a and p53: implication for gender difference in liver cancer developmentFung-Yu Huang, Danny Ka-Ho Wong, Wai-Kay Seto, et al.
The American Journal of Gastroenterology|December 16, 2010
Mild-to-moderate elevation of alanine aminotransferase increases liver stiffness measurement by transient elastography in patients with chronic hepatitis BJames Fung, Ching-Lung Lai, Charles Cheng, et al.
Journal of Clinical Microbiology|October 19, 2007
Hepatitis B virus core-related antigens as markers for monitoring chronic hepatitis B infectionDanny Ka-Ho Wong, Yasuhito Tanaka, Ching-Lung Lai, et al.
Expert Opinion on Therapeutic Targets|October 26, 2017
Hepatitis B core protein as a therapeutic targetLung-Yi Mak, Danny Ka-Ho Wong, Wai-Kay Seto, et al.
Journal of Hepatology|November 9, 2010
Profiles of HBV DNA in a large population of Chinese patients with chronic hepatitis B: implications for antiviral therapyJames Fung, Wai-Kay Seto, Ching-Lung Lai, et al.
Journal of Hepatology|June 7, 2020
Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significanceLung-Yi Mak, Danny Ka-Ho Wong, Teresa Pollicino, et al.
Pageof 48

Showing results (1-10 of 480) with videos related to

Sort By:
Pageof 48
The Lancet. Infectious Diseases|March 28, 2009
Prevention and management of drug resistance for antihepatitis B treatmentMan-Fung Yuen, James Fung, Danny Ka-Ho Wong, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 21, 2014
Hepatitis B surface antigen levels after hepatitis B e-antigen seroclearance: a longitudinal follow-up studyJames Fung, Wai-Kay Seto, Danny Ka-ho Wong, et al.
Journal of Clinical Microbiology|October 9, 2004
HBsAg seroclearance in Chinese patients receiving lamivudine therapy for chronic hepatitis B virus infectionMan-Fung Yuen, Danny Ka-Ho Wong, He-Jun Yuan, et al.
Antiviral Therapy|February 17, 2007
One-year entecavir or lamivudine therapy results in reduction of hepatitis B virus intrahepatic covalently closed circular DNA levelsDanny Ka-Ho Wong, Man-Fung Yuen, Vincent Wing-Shun Ngai, et al.
Oncotarget|October 7, 2015
Estradiol induces apoptosis via activation of miRNA-23a and p53: implication for gender difference in liver cancer developmentFung-Yu Huang, Danny Ka-Ho Wong, Wai-Kay Seto, et al.
The American Journal of Gastroenterology|December 16, 2010
Mild-to-moderate elevation of alanine aminotransferase increases liver stiffness measurement by transient elastography in patients with chronic hepatitis BJames Fung, Ching-Lung Lai, Charles Cheng, et al.
Journal of Clinical Microbiology|October 19, 2007
Hepatitis B virus core-related antigens as markers for monitoring chronic hepatitis B infectionDanny Ka-Ho Wong, Yasuhito Tanaka, Ching-Lung Lai, et al.
Expert Opinion on Therapeutic Targets|October 26, 2017
Hepatitis B core protein as a therapeutic targetLung-Yi Mak, Danny Ka-Ho Wong, Wai-Kay Seto, et al.
Journal of Hepatology|November 9, 2010
Profiles of HBV DNA in a large population of Chinese patients with chronic hepatitis B: implications for antiviral therapyJames Fung, Wai-Kay Seto, Ching-Lung Lai, et al.
Journal of Hepatology|June 7, 2020
Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significanceLung-Yi Mak, Danny Ka-Ho Wong, Teresa Pollicino, et al.
Pageof 48